496 related articles for article (PubMed ID: 32849827)
1. Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine.
Rahat B; Ali T; Sapehia D; Mahajan A; Kaur J
Front Genet; 2020; 11():844. PubMed ID: 32849827
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment.
Chaddha M; Rai H; Gupta R; Thakral D
Front Genet; 2023; 14():1138625. PubMed ID: 37091783
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell-free nucleic acids of plasma in human aging, healthy aging and longevity: current state of knowledge.
Tessier NP; Hardy LM; Deleuze JF; How-Kit A
Front Genet; 2023; 14():1321280. PubMed ID: 38090154
[TBL] [Abstract][Full Text] [Related]
4. Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box?
Benincasa G; Mansueto G; Napoli C
J Clin Pathol; 2019 Dec; 72(12):785-799. PubMed ID: 31611285
[TBL] [Abstract][Full Text] [Related]
5. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
[No Abstract] [Full Text] [Related]
7. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
[TBL] [Abstract][Full Text] [Related]
8. [Potential of Cell-free Circulating DNA in Diagnosis of Cancer].
Kubaczková V; Sedlaříková L; Bešše L; Almaši M; Hájek R; Ševčíková S
Klin Onkol; 2015; 28(4):251-9. PubMed ID: 26299738
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic IVD Tests for Personalized Precision Medicine in Cancer.
Beltrán-García J; Osca-Verdegal R; Mena-Mollá S; García-Giménez JL
Front Genet; 2019; 10():621. PubMed ID: 31316555
[TBL] [Abstract][Full Text] [Related]
10. Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.
Marin AM; Sanchuki HBS; Namur GN; Uno M; Zanette DL; Aoki MN
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189687
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
12. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.
Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP
Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic primer for diagnostic applications: a window into personalized medicine.
McNally B; Linder M; Valdes R
Per Med; 2014 May; 11(3):323-337. PubMed ID: 29764068
[TBL] [Abstract][Full Text] [Related]
15. Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers.
Karin-Kujundzic V; Sola IM; Predavec N; Potkonjak A; Somen E; Mioc P; Serman A; Vranic S; Serman L
Cells; 2019 Nov; 8(11):. PubMed ID: 31752198
[TBL] [Abstract][Full Text] [Related]
16. Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.
Mumford SL; Towler BP; Pashler AL; Gilleard O; Martin Y; Newbury SF
Biomolecules; 2018 Apr; 8(2):. PubMed ID: 29701682
[TBL] [Abstract][Full Text] [Related]
17. Circulating nucleic acids as a potential source for cancer biomarkers.
Vlassov VV; Laktionov PP; Rykova EY
Curr Mol Med; 2010 Mar; 10(2):142-65. PubMed ID: 20196731
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid-based tissue biomarkers of urologic malignancies.
Dietrich D; Meller S; Uhl B; Ralla B; Stephan C; Jung K; Ellinger J; Kristiansen G
Crit Rev Clin Lab Sci; 2014 Aug; 51(4):173-99. PubMed ID: 24878394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
